Current Position :
Pierre Amarenco, MDProfessor of Neurology at Paris University andChairman of the Department of Neurology and Stroke Centerat Bichat University Hospital46, rue Henri Huchard – 75018 Paris (France)Tel. : 331-40256023Fax. : 331-40257198email : pierre.amarenco@bch.aphp.fr&-DirectorINSERM Unit-1148 “Clinical Research in Atherothrombosis” team Paris, France N° CNOM : 75/49454 N° ADELI : 75 14 9454 3 N° RPPS : 10000375559
Education :
1980 Graduated from University of Paris Medical School
1986 Fellow in Neurology, Saint-Antoine University hospital, Paris
1995 Professor of neurology, Pierre and Marie Curie University, Paris
2001 Professor and Chairman, Paris University
Clinical training :
Neurology
Vascular Neurology
Editorial activity:
Consulting Editor, Stroke journal
Membership of society :
FAHA (Fellow of the American Heart Association)
FAAN (Fellow of the American Academy of Neurology)
ESO (European Stroke Organization) member (Board of Director)
R3i: steering committee member
Research interests
Understanding and preventing stroke and vascular diseases
Clinical trials in prevention of vascular diseases
Carotid intima-media thickness studies
Lipid and antithrombotic trials: prevention and therapeutic –protective- evaluation
Clinical trials:
Steering Committee member: SPARCL trial (showed efficacy of atorvastatin vs placebo in 4732 stroke/TIA patients: Amarenco et al. N Engl J Med. 2006;355:549-59)
Co-Chair of the Executive Committee the SOCRATES and THALES trial (AstraZeneca, N Engl J Med 2016 & 2020)
Executive Committee member: PERFORM trial (20,000 patients terutroban vs aspirin in secondary stroke prevention. Lancet 2009)
Chair of Steering Committee (PI): OPTIC registry, TIAregistry.org, TST (Treat Stroke to Target) trial, ARCH trial, RECANALISE trial, GENIC study, MASS study, Lacunar-B.I.C.HA.T. (Brain Infarction Cerebral Hyperreactivity and Atorvastatin Trial) registry and trial, AMISTAD study, HITS study
Publications:
More than 450 peer-reviewed publications including 8 in the New England Journal of Medicine as the first author.
